Literature DB >> 11139331

The human histone deacetylase family.

S G Gray1, T J Ekström.   

Abstract

Since the identification of the first histone deacetylase (Taunton et al., Science 272, 408-411), several new members have been isolated. They can loosely be separated into entities on the basis of their similarity to various yeast histone deacetylases. The first class is represented by its closeness to the yeast Rpd3-like proteins, and the second most recently discovered class has similarities to yeast Hda1-like proteins. However, due to the fact that several different research groups isolated the Hda1-like histone deacetylases independently, there have been various different nomenclatures used to describe the various members, which can lead to confusion in the interpretation of this family's functions and interactions. With the discovery of another novel murine histone deacetylase, homologous to yeast Sir2, the number of members of this family is set to increase, as 7 human homologues of this gene have been isolated. In the light of these recent discoveries, we have examined the literature data and conducted a database analysis of the isolated histone deacetylases and potential candidates. The results obtained suggest that the number of histone deacetylases within the human genome may be as high as 17 and are discussed in relation to their homology to the yeast histone deacetylases. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139331     DOI: 10.1006/excr.2000.5080

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  133 in total

Review 1.  Lung cancer therapeutics that target signaling pathways: an update.

Authors:  M Roshni Ray; David Jablons; Biao He
Journal:  Expert Rev Respir Med       Date:  2010-10       Impact factor: 3.772

2.  Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription.

Authors:  Anne Rascle; Emma Lees
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

3.  The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor.

Authors:  G B Potter; G M Beaudoin; C L DeRenzo; J M Zarach; S H Chen; C C Thompson
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

4.  Histone-modifying complexes regulate gene expression pertinent to the differentiation of the protozoan parasite Toxoplasma gondii.

Authors:  Nehmé Saksouk; Micah M Bhatti; Sylvie Kieffer; Aaron T Smith; Karine Musset; Jérôme Garin; William J Sullivan; Marie-France Cesbron-Delauw; Mohamed-Ali Hakimi
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 5.  Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy.

Authors:  Philip Lee; Ben Murphy; Rickey Miller; Vivek Menon; Naren L Banik; Pierre Giglio; Scott M Lindhorst; Abhay K Varma; William A Vandergrift; Sunil J Patel; Arabinda Das
Journal:  Anticancer Res       Date:  2015-02       Impact factor: 2.480

6.  Epigenetic Reactivation of Estrogen Receptor: Promising Tools for Restoring Response to Endocrine Therapy.

Authors:  Neeraj K Saxena; Dipali Sharma
Journal:  Mol Cell Pharmacol       Date:  2010

7.  Autoregulation of mouse histone deacetylase 1 expression.

Authors:  Bernd Schuettengruber; Elisabeth Simboeck; Harald Khier; Christian Seiser
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation.

Authors:  Chun Li Zhang; Timothy A McKinsey; Eric N Olson
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 9.  Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies.

Authors:  Nikhil G Thaker; Ian F Pollack
Journal:  Expert Rev Neurother       Date:  2009-12       Impact factor: 4.618

10.  The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2.

Authors:  Oliver H Krämer; Ping Zhu; Heather P Ostendorff; Martin Golebiewski; Jens Tiefenbach; Marvin A Peters; Boris Brill; Bernd Groner; Ingolf Bach; Thorsten Heinzel; Martin Göttlicher
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.